Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | MYL3 |
| Upstream (Parents) |
|---|
| (<<) ADCY6 → MYL3 |
| (<<) CAV3 → MYL3 |
| (<<) CLCF1 → MYL3 |
| (<<) CTRB2 → MYL3 |
| (<<) GALR3 → MYL3 |
| (<<) HDAC10 → MYL3 |
| (<<) HDAC11 → MYL3 |
| (<<) LCE3D → MYL3 |
| (<<) NDOR1 → MYL3 |
| (<<) TMPRSS11D → MYL3 |
| Downstream (Children) |
|---|
| MYL3 → ACTN3 (>>) |
| MYL3 → ATP10B (>>) |
| MYL3 → CDH24 (>>) |
| MYL3 → DYNLL1 (>>) |
| MYL3 → ENC1 (>>) |
| MYL3 → INE1 (>>) |
| MYL3 → KISS1R (>>) |
| MYL3 → KRT75 (>>) |
| MYL3 → NPBWR1 (>>) |
| MYL3 → PCSK7 (>>) |
| MYL3 → PLA2G4D (>>) |
| MYL3 → PLA2G6 (>>) |
| MYL3 → RNASE7 (>>) |
| MYL3 → SOX1 (>>) |
